CoChat
Sign Up
PreprintCited by 62Context-Aware Activity Recognition SystemsMobile Health and mHealth ApplicationsParkinson's Disease Mechanisms and Treatments

High Frequency Remote Monitoring of Parkinson's Disease via Smartphone: Platform Overview and Medication Response Detection

Open access
Zhan, Andong, Little, Max A., Harris, Denzil A., Abiola, Solomon O., Dorsey, E. Ray, Saria, Suchi, Terzis, Andreas·2016·arXiv
DOI 10.48550/arxiv.1601.00960arXiv 1601.00960
Open this paper in CoChat — free accountOpen PDF

Abstract

Objective: The aim of this study is to develop a smartphone-based high-frequency remote monitoring platform, assess its feasibility for remote monitoring of symptoms in Parkinson's disease, and demonstrate the value of data collected using the platform by detecting dopaminergic medication response. Methods: We have developed HopkinsPD, a novel smartphone-based monitoring platform, which measures symptoms actively (i.e. data are collected when a suite of tests is initiated by the individual at specific times during the day), and passively (i.e. data are collected continuously in the background). After data collection, we extract features to assess measures of five key behaviors related to PD symptoms -- voice, balance, gait, dexterity, and reaction time. A random forest classifier is used to discriminate measurements taken after a dose of medication (treatment) versus before the medication dose (baseline). Results: A worldwide study for remote PD monitoring was established using HopkinsPD in July, 2014. This study used entirely remote, online recruitment and installation, demonstrating highly cost-effective scalability. In six months, 226 individuals (121 PD and 105 controls) contributed over 46,000 hours of passive monitoring data and approximately 8,000 instances of structured tests of voice, balance, gait, reaction, and dexterity. To the best of our knowledge, this is the first study to have collected data at such a scale for remote PD monitoring. Moreover, we demonstrate the initial ability to discriminate treatment from baseline with 71.0(+-0.4)% accuracy, which suggests medication response can be monitored remotely via smartphone-based measures.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

DataCite · 10.48550/arxiv.1601.00960

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Wearable sensor-based, quantitative, objective, and easy-to-use systems for quantifying PD signs for large numbers of participants over extended durations have been developed.

    “More recently, 'wearable', sensor-based, quantitative, objective, and easy-to-use systems for quantifying PD signs for large numbers of participants over extended durations have been developed.”

    From Machine learning for large‐scale wearable sensor data in Parkinson's disease: Concepts, promises, pitfalls, and futures (2016) · cites this paper as [6]

    The Background (p. 2) says wearable sensors had been used to quantify PD signs, but describes those studies as small and short, unlike the large-scale, six-month monitoring enabled by the authors’ smartphone platform. The Discussion (p. 8) also distinguishes that platform from wearable devices. The claim combines the platform’s scale and duration with the wearable systems discussed as earlier work. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

  • Sensor data from short controlled tests allowed a machine learning algorithm to quantify the level of responsiveness to treatments against l-dopa equivalent dosage.

    “and to quantify the level of responsiveness to treatments against l-dopa equivalent dosage.”

    From Machine learning for large‐scale wearable sensor data in Parkinson's disease: Concepts, promises, pitfalls, and futures (2016) · cites this paper as [6]

    The Methods (p. 4) describe a random forest classifier using short active tests to distinguish measurements taken before and after medication. The Results (p. 8) plot each participant’s detection accuracy against daily levodopa equivalent dose and compare feature changes in two participants, but do not show the algorithm quantifying the degree of treatment responsiveness against dose. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 29 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. [26][26] S. Arora, V. Venkataraman, S. Donohue, K. M. Biglan, E. R. Dorsey, and M. A. Little, 'High accuracy discrimination of parkinson's disease participants from healthy controls using smartphones,' in Movement Disorders , vol. 28, no. 10, 2013, pp. E11-E11. -

Cited by

Sorted by citations

Related

Authors
Zhan, A., Little, M. A., Harris, D. A., Abiola, S. O., Dorsey, E. R., Saria, S., & Terzis, A.
Affiliations
  • Johns Hopkins University (US)
  • University of Rochester Medicine (US)
ORCID
Venue
arXiv
Publisher
arXiv
Published
2016
ISSN
2331-8422 (ISSN-L)
DOI
10.48550/arxiv.1601.00960
arXiv
1601.00960
OpenAlex
W2229990841
Cited by
50
References
29
Citations by year
2024: 1 · 2023: 4 · 2022: 3 · 2021: 6 · 2020: 11 · 2019: 7 · 2018: 6 · 2017: 11 · 2016: 1
Type
posted content
Language
en
Open access
Licence
arxiv.org/licenses/nonexclusive-distrib/1.0/
Locations
  • arXiv (Cornell University) (submittedVersion)
  • arXiv (Cornell University)
Topics
  • Physical Sciences › Computer Science › Computer Vision and Pattern Recognition › Context-Aware Activity Recognition Systems
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
Keywords
Parkinson's disease, remote symptom monitoring, smartphone-based monitoring, medication adherence, voice analysis, balance, gait, dexterity, reaction time, passive data collection, random forest classification, online recruitment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review